MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2019 International Congress

    Clinimetric properties of direct contemporaneous FOG score rating

    K. Ziegler, AO. Ceballos-Baumann, UM. Fietzek (Munich, Germany)

    Objective: To determine the clinimetric properties of the direct rating of the Freezing of Gait (FOG) score compared to the off-line rating from video recordings.…
  • 2019 International Congress

    Assessment of the risk of falls in patients with Parkinson’s disease using Time Up and Go

    F. Sattolo, L. Rodrigues, L. Lima, M. Diogo, R. Guimarães (Campinas, Brazil)

    Objective: This study aimed to evaluate the risk of falls in patients participating in the group of physical activities for Parkinson's of UNICAMP using the…
  • 2019 International Congress

    Natural History of Movement Abnormalities on Hereditary Spastic Paraplegia: validation of timed functional instruments

    J. Saute, G. Machado, AP. Zanardi, V. Martins, D. Burguêz, L. Jacinto-Scudeiro, E. Monteiro, L. Peyré-Tartaruga (Porto Alegre, Brazil)

    Objective: To evaluate the natural history of Hereditary Spastic Paraplegia (HSPs) and to define sensitivity to change, minimal clinically important difference (MCID) and validity of…
  • 2019 International Congress

    Prevalence of chronic kidney disease in patients with idiopathic Parkinson’s disease in a tertiary care hospital in Mexico City

    S. Isais-Millan, CA. Rojas-Guerrero, A. Arriaga, M. Rodriguez-Violante, D. Zuñiga-Garcia, RO. Millan-Guerrero, V. Campos-Gasga, V. Garcia-Barrera, R. Santos-Montero (Colima, Mexico)

    Objective: To describe the prevalence of chronic kidney disease (CKD) in patients with idiopathic Parkinson's disease (PD) and to determine the association between renal function…
  • 2019 International Congress

    Quantitative EEG measures reflect general cognitive status in Parkinson’s disease

    C. Navarro-Roa, M. Rodriguez-Violante, G. Sanchez-Dinorin, A. Cervantes-Arriaga, R. Solis-Vivanco (Mexico City, Mexico)

    Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…
  • 2019 International Congress

    Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in de-novo diagnosed Parkinson patients

    F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, W. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)

    Objective: To determine the reliability and validity of a novel, comprehensive digital biomarker remote monitoring approach to actively and passively measure motor symptom progression in…
  • 2019 International Congress

    Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions

    A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)

    Objective: To explore the views of PD healthcare professionals on the use of e-PROMs. Background: Assessment of motor AND non-motor symptoms are critical to the…
  • 2019 International Congress

    Reliability, feasibility and validity of a novel digital monitoring platform assessing cognitive and motor symptoms in people with Stage I and II Huntington’s disease (HD)

    F. Lipsmeier, C. Simillion, A. Atieh Bamdadian, A. Smith, S. Schobel, C. Gossens, P. Weydt, E. Wild, M. Lindemann (Basel, Switzerland)

    Objective: To determine the reliability and convergent validity of a novel digital monitoring platform offering objective, daily assessment of cognitive and motor symptom severity in…
  • 2019 International Congress

    Digital biomarker sensor feature data reflect quality of life judgements (PDQ39) in recently diagnosed Parkinson’s disease patients

    F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, H. Staunton, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, WY. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)

    Objective: To evaluate the extent to which data derived from smartphone-based testing and passive monitoring are related to what recently diagnosed Parkinson’s disease (PD) patients…
  • 2019 International Congress

    How reliable are non-blinded evaluations of motor UPDRS? a comparison of blinded vs. un-blinded UPDRS scores in 14 patients with advanced Parkinson´s disease

    G-M. Hariz, A. Fredricks, R. Stenmark, J. Linder, M. Hariz, L. Forsgren, P. Blomstedt (Umea, Sweden)

    Objective: To investigate the reliability of scores of the motor part of the Unified Parkinson Disease Rating Scale (UPDRS III) rated by an un-blinded specialist…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley